Dr. Engelhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of North Carolina HospitalsResidency, Internal Medicine, 2000 - 2003
Case Western Reserve University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2006 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 2000 - 2008- American Board of Internal Medicine Hematology
Clinical Trials
- The Treatment of Hematologic Malignancies With Single or Double Umbilical Cord Blood Unit Transplantation Followed by Graft-Versus-Host Disease Prophylaxis With Tacrolimus and Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsTP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia.Jennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, Reena V Jayani, Bhagirathbhai Dholaria
Transplantation and Cellular Therapy. 2023-06-01 - 10 citationsNoninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation.Johnathan Fraebel, Brian G Engelhardt, Tae Kon Kim
Transplantation and Cellular Therapy. 2023-02-01 - 12 citationsFeasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience.Bhagirathbhai Dholaria, Nasima Mehraban, Brittney Baer, Nancy Long, Reena V Jayani
British Journal of Haematology. 2022-09-01
Press Mentions
Post-Transplant Diabetes May Be ReversibleFebruary 21st, 2020
Research Explores Link Between Stem Cell Transplant, DiabetesJanuary 17th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
